Skip to main content

Table 4 Comparison of BSM without EMD to BSM + EMD on osteogenic cell proliferation after 24 h and 7 d using the t-test

From: In vitro proliferation of human osteogenic cells in presence of different commercial bone substitute materials combined with enamel matrix derivatives

24 h

   

Comparison

Diff of Means

t

p

BIO vs. BIO + EMD

-54

-2.5

0,06

NBO vs. NBO + EMD

-93

-3.4

0,025 *

BRE vs. BRE + EMD

-93

-5.7

0,004 *

CBM vs. CBM + EMD

-71

-2.3

0,078

PGL vs. PGL + EMD

+4

0.4

0,686

BOC vs. BOC + EMD

-82

-2.2

0,086

BIM vs. BIM + EMD

+2

-1.4

0,231

7d

   

Comparison

Diff of Means

T

p

BIO vs. BIO + EMD

-139

-3.3

0.028 *

NBO vs. NBO + EMD

-48

-0.4

0.701

BRE vs. BRE + EMD

-83

-0.3

0.400

CBM vs. CBM + EMD

+38

-0.4

0.663

PGL vs. PGL + EMD

-3

-0.1

0.911

BOC vs. BOC + EMD

-29

-0.2

0.787

BIM vs. BIM + EMD

-210

-1.4

0.231

  1. (BIO = Bio-Oss®, NBO = NanoBone®, BRE = Bioresorb®, CBM = Cerasorb® M, PGL = PerioGlas®, BOC = Straumann® BoneCeramic, BIM = BONIT®matrix; t = probability; p = p-value; *significant).